BeastLife Raises $2.1M Pre-Series A Round From GVFL and Equentis

Why It Matters

The capital injection accelerates BeastLife’s transition from online‑only to a hybrid model, positioning it to capture a larger share of India’s fast‑growing nutrition market and signaling confidence in D2C brands’ profitability potential.

Key Takeaways

• Raised $2.1M at $34M valuation.
• Founder Gaurav Taneja leverages influencer following.
• Plans offline expansion across western and southern India.
• Targets $13M FY26 revenue, $61M in three years.
• D2C supplement market draws heightened investor interest.

Pulse Analysis

India’s health‑and‑wellness sector is witnessing a surge of influencer‑backed D2C brands, and BeastLife exemplifies this trend. Leveraging Gaurav Taneja’s massive social media following, the startup has built a loyal customer base for protein powders, creatine, and mass gainers, primarily through its website and quick‑commerce partners. This model reduces traditional retail overhead while delivering personalized nutrition, a formula that resonates with a digitally native, fitness‑focused audience. The recent funding round not only validates the brand’s market fit but also reflects a broader shift toward direct‑to‑consumer channels that prioritize speed, data‑driven product development, and community engagement.

The ₹20 Cr infusion brings BeastLife to a post‑money valuation of roughly $34 million, a notable benchmark for a company founded just two years ago. Crucially, the brand is already net‑profitable and expects FY26 revenue near $13 million, with an ambitious target of $61 million in three years. The capital will be allocated to scaling the workforce, enhancing supply‑chain capabilities, and launching a measured offline presence in key western and southern markets. By testing brick‑and‑mortar formats, BeastLife aims to capture consumers who still prefer tactile shopping experiences, while maintaining its strong e‑commerce backbone.

BeastLife’s trajectory mirrors a wave of investor enthusiasm for the Indian supplement space, highlighted by recent mega‑deals such as The Whole Truth’s $51 million Series D and USV Pharma’s $190 million acquisition of Wellbeing Nutrition. As health awareness rises, D2C nutrition brands are poised for consolidation and potential public listings. BeastLife’s profitability and clear expansion roadmap position it as a compelling candidate for future strategic partnerships or a possible IPO, offering investors exposure to a high‑growth, consumer‑centric segment of the Indian economy.

Deal Summary

Indian D2C nutrition brand BeastLife announced it has closed a pre‑Series A funding round, raising ₹20 Cr (≈$2.1 M) from investors GVFL and Equentis at a ₹320 Cr (≈$34 M) post‑money valuation. The capital will fund team expansion, offline retail rollout and new product development. BeastLife, founded in 2024 by fitness influencer Gaurav Taneja and ex‑mCaffeine exec Raj Vikram Gupta, is already profitable and targeting ₹500 Cr revenue in three years.